Never Miss a Potential Recovery Again

Sign up for Class
Action Alerts

Each year, class action lawsuits generate billions of dollars in settlement funds, but many shareholders fail to file a claim. Stay in the know regarding class action lawsuits by signing up for alerts.

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.

$1,012,319,952 in Total Settlement Funds Available. See if you qualify!Find Out More

We Give Shareholders A Voice.

The market fluctuates, but we don’t. We give you straight answers from real attorneys who have spent decades helping shareholders protect their investments and recover their losses.

Settlements

$24.6 Million

Loma Negra Industrial Argentina Sociedad Argentina

$14 Million

Corcept Therapeutics Incorporated

$9.5 Million

Babcock & Wilcox Enterprises, Inc.

$40 Million

U.S. Steel

$7 Million

Aqua Metals, Inc.

$7.025 Million

WideOpenWest, Inc.

$8.25 Million

Helios and Matheson Analytics Inc.

$13.85 Million

Illumina, Inc.

$14.5 Million

Avon Products Inc.

I think you’ve done a superb job and I really appreciate the way this case was handled.

The Honorable Ronald B. Rubin in Teoh v. Ferrantino, C.A. No. 356627 (Cir. Ct. for Montgomery Cnty., MD 2012)

…a model for how [the] great legal profession should conduct itself.

Justice Timothy S. Driscoll in Grossman v. State Bancorp, Inc., Index No. 600469/2011 (N.Y. Sup. Ct. Nassau Cnty. Nov. 29, 2011)

I find the firm to be well-qualified to serve as Lead Counsel.

The Honorable Andrew L. Carter, Jr. In Snyder v. Baozun Inc., No. 1:19-CV-11290 (S.D.N.Y. Sept. 8, 2020)

In appointing the Firm Lead Counsel, the Honorable Analisa Torres noted our “extensive experience” in securities litigation.

White Pine Invs. v. CVR Ref., LP, No. 20 CIV. 2863 (S.D.N.Y. Jan. 5, 2021)

Class Counsel have demonstrated that they are skilled in this area of the law and therefore adequate to represent the Settlement Class as well.

Furthermore, with the increasing importance of compliance and risk management, kyc for law firms has become an essential component of legal services.

The Honorable Barry Ted Moskowitz in In re Regulus Therapeutics Inc. Sec. Litig., No. 3:17-CV-182-BTM-RBB (S.D. Cal. Oct. 30, 2020)

Who We Are

We combine specialized securities expertise with an innovative approach to litigation and an enduring commitment to our clients. We represent individuals, institutions, and asset managers in some of the largest, most complex securities cases in the country and never shy away from an uphill battle.

Online casinos that accept a minimum deposit of $10 are a great option for players who want to try out their luck without risking too much money. These 10 dollar deposit casinos offer a variety of games, including slots, table games, and live dealer games, as well as various payment options to make depositing and withdrawing funds easy.

Nos últimos anos, os casinos online tornaram-se extremamente populares, e um número crescente de jogadores está a optar por fazê-lo a partir do conforto das suas próprias casas. Um dos métodos de pagamento mais bem aceites pelos casinos online é o PayPal, uma carteira digital que permite aos utilizadores depositar e receber dinheiro de forma simples e segura. Os casinos PayPal são estabelecimentos de jogo online que aceitam PayPal como forma de pagamento.
A popularidade do PayPal como método de pagamento de casino online pode ser atribuída tanto à sua usabilidade como às suas características de segurança. Quando utiliza o PayPal para fazer um depósito ou levantamento num casino, não precisa de dar ao casino acesso aos seus dados financeiros pessoais. Apenas precisa do seu endereço de e-mail e palavra-passe PayPal para completar a transacção. Isto reduz significativamente a probabilidade de fraude e roubo de identidade. Além disso, as transacções PayPal são processadas rapidamente, permitindo-lhe começar quase imediatamente a jogar os jogos de casino que escolheu.

Mi is a status company working with securities and innovative approaches with online casino gamblers. We provide you with an open door to our offices where online casino players can view a win palace review. Our company, together with online casinos, works in more than 40 courts throughout the country and is considered the best company.

O facto de o PayPal ser amplamente reconhecido é um benefício adicional da sua utilização num casino online pagamento Paypal. Porque o PayPal é um método de pagamento fiável e bem respeitado, vários casinos online decidiram incluí-lo na sua lista de métodos de pagamento aprovados. Tem agora opções adicionais para jogar porque uma variedade de casinos em linha aceita PayPal para depósitos e levantamentos.
Um casino PayPal é um casino online que aceita PayPal como uma forma de pagamento. Ao optar por financiar as suas contas em casinos online com PayPal, os jogadores têm uma opção segura, segura e útil. Dada a sua conveniência, características de segurança, e aceitação geral, faz sentido que o PayPal se tenha tornado um dos métodos de pagamento mais frequentemente utilizados para casinos online. Se procura um método de pagamento fiável e de confiança para as suas actividades de jogo online, pense em utilizar PayPal num casino que aceite PayPal.

In the fast-paced world of online casinos, one of the most critical elements to ensuring that their business is legally compliant is working with the best lawyers. The legal landscape around online gambling is complex and constantly evolving, making it essential for online casinos to have legal experts on hand to help navigate this tricky terrain. In this article, we will explore how online casinos cooperate with the best lawyers and why this is essential to their success. Firstly, working with the best lawyers can help online casinos https://casinosworld.ca/best-payout-online-casinos/ ensure that they are operating within the confines of the law. Online gambling regulations can vary significantly from jurisdiction to jurisdiction, and it can be challenging for online casinos to stay on top of the latest changes. By working with experienced lawyers who specialize in gambling law, online casinos can be confident that they are always up to date with the latest legal developments and that their business is fully compliant.

Ice hockey is one of the most exciting and dynamic sports in the world, and it’s no surprise that many people enjoy betting on it. However, one group of professionals that has taken a particular interest in hockey betting is lawyers and attorneys. In this article, we will explore why hockey betting is popular among lawyers and attorneys and what they enjoy about this unique form of gambling. One reason that lawyers and attorneys enjoy hockey betting is that it requires a deep understanding of the game and its rules. As legal professionals, they are trained to analyze complex information and make informed decisions based on that information. This analytical approach is well-suited to sports betting, where successful bettors must understand the intricacies of the game and make informed decisions based on those details. Hockey betting provides a unique challenge that many lawyers and attorneys find appealing. Another reason that hockey betting https://thewincolumn.ca/2023/02/11/sports-betting-101-how-to-bet-on-hockey/ is popular among lawyers and attorneys is that it allows them to stay up to date with the latest legal developments in the sports world. As legal professionals, they are always looking for new opportunities to expand their knowledge and expertise. By betting on hockey, they can stay up to date with the latest developments in the sport, including any changes to the rules or regulations that may affect betting odds.

1
1
1
1
1
1

We're here for you

Find an Attorney

Required Field

Coin Image

Don't hesitate

Find a Case

Upcoming Deadlines

Investors interested in taking an active role in litigation have a limited time to petition the court for appointment as lead plaintiff. If you are interested in acting as a lead plaintiff, submit your transactions before the deadline, and our analysts will calculate your losses. Don't wait till the last minute- discuss your options today.
View All Deadlines

2

Days Left

MAPS

WM Technology, Inc.

Deadline

December 16 2024

Class Period

5/25/21 - 9/24/24

Allegations

According to the filed complaint, defendants made false statements and/or concealed that: defendants acted with scienter in that they knew that the public documents and statements issued or disseminated in the name of the Company were materially false and misleading; knew that such statements or documents would be issued or disseminated to the investing public; and knowingly and substantially participated, or acquiesced in the issuance or dissemination of such statements or documents as primary violations of the securities laws. These defendants by virtue of their receipt of information reflecting the true facts of the Company, their control over, and/or receipt and/or modification of the Company’s allegedly materially misleading statements, and/or their associations with the Company which made them privy to confidential proprietary information concerning the Company, participated in the fraudulent scheme alleged herein.

Class Period

5/25/21 - 9/24/24

Deadline

December 16 2024

Learn More

2

Days Left

AIXI

Xiao-I Corporation

Deadline

December 16 2024

Class Period

3/9/23 - 7/12/24

Allegations

(i) defendants had downplayed the true scope and severity of risks that Xiao-I faced due to certain of its Chinese shareholders’ non-compliance with foreign investment enterprises established by way of round-tripping, including the Company’s inability to use offering proceeds for intended business purposes; (ii) Xiao-I had failed to comply with Generally Accepted Accounting Principles in preparing its financial statements; (iii) defendants had overstated Xiao-I’s efforts to remediate material weaknesses in the Company’s financial controls; (iv) Xiao-I was forced to incur significant R&D expenses to effectively compete in the AI industry; (v) Xiao-I had downplayed the significant negative impact that such expenses would have on the Company’s business and financial results; (vi) accordingly, Xiao-I overstated its AI capabilities, R&D resources, and overall ability to compete in the AI market; (vii) as a result of all the foregoing, there was a substantial likelihood that Xiao-I would fail to comply with the NASDAQ’s Minimum Bid Price Requirement; and (viii) as a result, the offering documents and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

Class Period

3/9/23 - 7/12/24

Deadline

December 16 2024

Learn More

9

Days Left

TD

The Toronto-Dominion Bank

Deadline

December 23 2024

Class Period

2/29/24 - 10/9/24

Allegations

According to the complaint, on October 10, 2024, TD unveiled the resolutions reached from United States investigations, which included, in addition to the punitive payment of $3.09 billion, both an asset cap, preventing TD’s U.S. subsidiaries from exceeding a collective $434 billion, a reflection of the Company’s assets as of September 30, 2024, and further subjects TD to more stringent approval processes for its product, service, and market rollouts. Further, the Department of Justice, in their own corresponding release, highlighted the significance of TD’s failures as “the largest bank in U.S. history to plead guilty to Bank Secrecy Act program failures, and the first US bank in history to plead guilty to conspiracy to commit money laundering.” The unveiling of the scope of the Company’s anti-money laundering failures surprised investors and analysts alike as they reacted immediately to the revelations. The price of TD’s common stock declined dramatically. From a closing market price of $63.51 per share on October 9, 2024, TD’s stock price fell to $59.44 per share on October 10, 2024, and further to $57.01 on October 11, 2024, a decline of more than 10.23% in the span of just two days.

Class Period

2/29/24 - 10/9/24

Deadline

December 23 2024

Learn More

17

Days Left

EVLV

Evolv Technologies Holdings, Inc.

Deadline

December 31 2024

Class Period

8/19/22 - 10/30/24

Allegations

According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that: Company’s financial statements prepared for the periods between Q2 2022 through Q2 2024 contained material misstatements relating to improper revenue recognition and other reported metrics that are a function of revenue. In truth, Evolv’s sales, including sales to one of its largest channel partners, were subject to extra-contractual terms and conditions not shared with the Company’s accounting personnel, distorting the Company’s reported revenue and other metrics that are a function of revenue during the Class Period. What’s more, far from the Company’s touted “growing momentum” and “continued traction” with channel partners, the Company’s personnel was engaged in misconduct concerning sales to one of the Company’s largest channel partners.

Class Period

8/19/22 - 10/30/24

Deadline

December 31 2024

Learn More

23

Days Left

LILM

Lilium N.V.

Deadline

January 6 2025

Class Period

6/11/24 - 11/3/24

Allegations

(1) defendants overstated the progress of the Company’s fundraising activities; (2) defendants overstated the likelihood and/or feasibility of obtaining sufficient funding to continue operations; (3) defendants failed to sufficiently disclose the imminent insolvency of the Company and its subsidiaries; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

6/11/24 - 11/3/24

Deadline

January 6 2025

Learn More

27

Days Left

CMG

Chipotle Mexican Grill, Inc.

Deadline

January 10 2025

Class Period

2/8/24 - 10/29/24

Allegations

(1) Chipotle’s portion sizes were inconsistent and left many customers dissatisfied with the Company’s offerings; (2) in order to address the issue and retain customer loyalty, the Company would have to ensure more generous portion sizes, which would increase cost of sales; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

2/8/24 - 10/29/24

Deadline

January 10 2025

Learn More

30

Days Left

PAC

PACS Group, Inc.

Deadline

January 13 2025

Class Period

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s April 11, 2024 initial public offering; and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive.

Allegations

(1) the Company engaged in a “scheme” to submit false Medicare claims which “drove more than 100% of PACS’ operating and net income from 2020 – 2023”; (2) the Company engaged in a “scheme” to “bill thousands of unnecessary respiratory and sensory integration therapies to Medicare”; (3) the Company engaged in a scheme to falsify documentation related to licensure and staffing; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s April 11, 2024 initial public offering; and/or (b) securities between April 11, 2024 and November 5, 2024 inclusive.

Deadline

January 13 2025

Learn More

30

Days Left

ASML

ASML Holding N.V.

Deadline

January 13 2025

Class Period

1/24/24 - 10/15/24

Allegations

(1) the issues being faced by suppliers, like ASML, in the semiconductor industry were much more severe than defendants had indicated to investors; (2) the pace of recovery of sales in the semiconductor industry was much slower than defendants had publicly acknowledged; (3) defendants had created the false impression that they possessed reliable information pertaining to customer demand and anticipated growth, while also downplaying risk from macroeconomic and industry fluctuations, as well as stronger regulations restricting the export of semiconductor technology, including the products that ASML sells; and (4) as a result, defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

Class Period

1/24/24 - 10/15/24

Deadline

January 13 2025

Learn More

30

Days Left

HAS

Hasbro, Inc.

Deadline

January 13 2025

Class Period

2/7/22 - 10/25/23

Allegations

According to the filed complaint, it is alleged that defendants made numerous materially false and misleading statements and omissions about the quality inventory that Hasbro held throughout the class period, and represented that its rising inventory levels reflected outstanding and anticipated demand, rather than excess supply that outpaced waning demand. As a result of the foregoing, Hasbro common stock traded at artificially inflated prices throughout the Class Period and defendants’ statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

2/7/22 - 10/25/23

Deadline

January 13 2025

Learn More

34

Days Left

WOLF

Wolfspeed, Inc.

Deadline

January 17 2025

Class Period

8/16/23 - 11/6/24

Allegations

According to the complaint, defendants provided the public with revenue projections that depended on Wolfspeed’s Mohawk Valley fabrication facility ramping its production to meet and/or exceed demand for its 200mm wafer product. On November 6, 2024, Wolfspeed announced its financial results for the first quarter of fiscal year 2025 and unveiled guidance for the second quarter well below expectations. While defendants had repeatedly claimed that 20% utilization of the Mohawk Valley fabrication facility would result in $100 million revenue out of the facility, defendants now guided to a range 30% to 50% below that mark. The Company attributed its results and lowered guidance to “demand … ramp[ing] more slowly than we originally anticipated” as “EV customers revise their launch time lines as the market works though this transition period.” Investors and analysts reacted immediately to Wolfspeed’s revelation. The price of Wolfspeed’s common stock declined dramatically. From a closing market price of $13.71 per share on November 6, 2024, Wolfspeed’s stock price fell to $8.33 per share on November 7, 2024, a decline of about 39.24% in the span of just a single day.

Class Period

8/16/23 - 11/6/24

Deadline

January 17 2025

Learn More

34

Days Left

HUMA

Humacyte, Inc.

Deadline

January 17 2025

Class Period

5/10/24 - 10/17/24

Allegations

(1) the Company’s Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) the FDA’s review of the biologics license application would be delayed while Humacyte remediated these deficiencies; and (3) as a result, there was a substantial risk to FDA approval of acellular tissue engineered vessel for vascular trauma; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

5/10/24 - 10/17/24

Deadline

January 17 2025

Learn More

38

Days Left

V

Visa Inc.

Deadline

January 21 2025

Class Period

11/16/23 - 9/23/24

Allegations

(1) Visa was not in compliance with federal antitrust laws; (2) Visa did not have effective internal programs and policies to assess and control compliance with federal antitrust laws; and (3) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Class Period

11/16/23 - 9/23/24

Deadline

January 21 2025

Learn More

38

Days Left

XRX

Xerox Holdings Corporation

Deadline

January 21 2025

Class Period

1/25/24 - 10/28/24

Allegations

(1) after a large workforce reduction, the Company’s salesforce was reorganized with new territory assignments and account coverage; (2) as a result, the Company’s salesforce productivity was disrupted; (3) as a result, the Company had a lower rate of sell-through of older products; (4) the difficulties in flushing out older product would delay the launch of key products; (5), as a result, Xerox was likely to experience lower sales and revenue; and (6) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

1/25/24 - 10/28/24

Deadline

January 21 2025

Learn More

38

Days Left

CELH

Celsius Holdings, Inc.

Deadline

January 21 2025

Class Period

2/29/24 - 9/4/24

Allegations

(i) the Company deceived the investing public regarding Celsius’ prospects and business; (ii) artificially inflated the market price of Celsius common stock; (iii) allowed certain officers, directors, and insiders to generate enormous insider proceeds by selling more than 21.6 million of their personally held shares of Celsius common stock at artificially inflated prices, reaping more than $1.4 billion; and (iv) caused plaintiff and other members of the class to purchase Celsius common stock at artificially inflated prices and suffer damages as the true facts regarding Celsius were revealed.

Class Period

2/29/24 - 9/4/24

Deadline

January 21 2025

Learn More

38

Days Left

ZETA

Zeta Global Holdings Corp.

Deadline

January 21 2025

Class Period

2/27/24 - 11/13/24

Allegations

(1) Zeta used two-way contracts to artificially inflate financial results; (2) Zeta engaged in round trip transactions to artificially inflate financial results; (3) Zeta utilized predatory consent farms to collect user data; (4) these consent farms have driven almost the entirety of Zeta’s growth; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

2/27/24 - 11/13/24

Deadline

January 21 2025

Learn More

41

Days Left

WBD

Warner Bros. Discovery, Inc.

Deadline

January 24 2025

Class Period

2/23/24 - 8/7/24

Allegations

(i) WBD’s sports rights negotiations with the NBA were causing, or were likely to cause, the Company to significantly reevaluate its business and goodwill; (ii) WBD’s goodwill in its Networks segment had significantly deteriorated as a result of the difference between its market capitalization and book value, continued softness in certain U.S. advertising markets, and uncertainty related to affiliate and sports rights renewals, including with the NBA; (iii) the foregoing significantly increased the likelihood of WBD incurring billions of dollars in goodwill impairment charges; (iv) accordingly, defendants had overstated WBD’s overall business and financial prospects; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

2/23/24 - 8/7/24

Deadline

January 24 2025

Learn More

41

Days Left

MTCH

Match Group, Inc.

Deadline

January 24 2025

Class Period

5/2/23 - 11/6/24

Allegations

(1) Match Group materially understated the challenges affecting Tinder and, as a result, understated the risk that Tinder’s monthly active user count would not recover by the time the Company reported its financial results for the third quarter of 2024; and (2) as a result, defendants’ statements about Match Group’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

5/2/23 - 11/6/24

Deadline

January 24 2025

Learn More

44

Days Left

RTO

Rentokil Initial plc

Deadline

January 27 2025

Class Period

12/1/23 - 9/10/24

Allegations

(1) Rentokil experienced levels of disruption in the early pilots of the Terminix integration; (2) Rentokil experienced significant, ongoing, self-inflicted execution challenges integrating Terminix; (3) the disruption and execution challenges imperiled Rentokil’s integration plan for Terminix; (4) Rentokil and Terminix were still two separate businesses that were not yet integrated; (5) Rentokil’s failure to integrate Terminix negatively impacted the Company’s business and operations, particularly organic revenue growth in North America; and (6) as a result of the above, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

12/1/23 - 9/10/24

Deadline

January 27 2025

Learn More

44

Days Left

XRAY

Dentsply Sirona Inc.

Deadline

January 27 2025

Class Period

12/1/22 - 11/6/24

Allegations

(1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a DTC aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (6) Dentsply had no systems in place to notify the FDA of these injuries, which the Company is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; (9) as a result of the above, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

12/1/22 - 11/6/24

Deadline

January 27 2025

Learn More

48

Days Left

CUBI

Customers Bancorp, Inc.

Deadline

January 31 2025

Class Period

3/1/24 - 8/8/24

Allegations

(1) Customers Bancorp had inadequate anti-money laundering practices; (2) as a result, it was not in compliance with its legal obligations, which subjected it to heightened regulatory risk; and (3) as a result, defendants’ statements about Customers Bancorp’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

Class Period

3/1/24 - 8/8/24

Deadline

January 31 2025

Learn More

51

Days Left

ASPI

ASP Isotopes Inc.

Deadline

February 3 2025

Class Period

10/30/24 - 11/26/24

Allegations

(1) the Company overstated the potential effectiveness of its enrichment technology; (2) the Company overstated the development potential of its high assay low-enriched uranium facility; (3) the Company overstated the Company’s nuclear fuels operating segment results; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

10/30/24 - 11/26/24

Deadline

February 3 2025

Learn More

51

Days Left

SYM

Symbotic Inc.

Deadline

February 3 2025

Class Period

2/8/24 - 11/26/24

Allegations

(1) Symbotic improperly accelerated revenue recognition in its 2024 financial statements; and (2) as a result, defendants’ statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

2/8/24 - 11/26/24

Deadline

February 3 2025

Learn More

51

Days Left

AEHR

Aehr Test Systems, Inc.

Deadline

February 3 2025

Class Period

1/9/24 - 3/24/24

Allegations

(i) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders; (ii) the foregoing issue was likely to have a material negative impact on the Company’s revenue growth; (iii) accordingly, the Company’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

1/9/24 - 3/24/24

Deadline

February 3 2025

Learn More

51

Days Left

FIVN

Five9, Inc.

Deadline

February 3 2025

Class Period

6/4/24 - 8/8/24

Allegations

(i) Five9’s net new business was not “strong irrespective of the macro” and was, in fact, hampered by macroeconomic issues such as constrained and scrutinized customer budgets; (ii) Five9 was in the midst of a challenging bookings quarter due, in part, to sales execution and efficiency issues, and the Company was not “seeing very strong bookings momentum”; and (iii) defendants did not have “enough information in terms of [their] existing customers that are going live” such that the statements that Five9 would see a positive inflection in its dollar-based retention rate lacked a reasonable basis.

Class Period

6/4/24 - 8/8/24

Deadline

February 3 2025

Learn More

52

Days Left

BOOM

DMC Global Inc.

Deadline

February 4 2025

Class Period

5/3/24 - 11/4/24

Allegations

(i) the goodwill associated with Acadia products was overstated due to the adverse events and circumstances affecting that reporting segment; (ii) DMC Global’s materially inadequate internal systems and processes were adversely affecting its operations; (iii) the Company’s inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; (iv) as a result, defendants misrepresented DMC Global’s operations and financial results; and/or (v) as a result, the Company’s public statements were materially false, misleading, or lacked a reasonable basis when made.

Class Period

5/3/24 - 11/4/24

Deadline

February 4 2025

Learn More

55

Days Left

MQ

Marqeta, Inc.

Deadline

February 7 2025

Class Period

8/7/24 - 11/4/24

Allegations

(1) Marqeta understated the regulatory challenges affecting its business outlook; (2) as a result, Marqeta would have to cut its guidance for the fourth quarter of 2024 and; (3) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.

Class Period

8/7/24 - 11/4/24

Deadline

February 7 2025

Learn More

55

Days Left

KYTX

Kyverna Therapeutics, Inc.

Deadline

February 7 2025

Class Period

This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and/or traceable to the Company's offering documents issued in connection with its February 2024 initial public offering.

Allegations

(i) the strategy to best accomplish the IPO; (ii) the terms of the IPO, including the price at which Kyverna’s common stock would be sold; (iii) the language to be used in the Offering Documents; (iv) what disclosures about Kyverna would be made in the Offering Documents; and (v) what responses would be made to the SEC in connection with its review of the Offering Documents. As a result of those constant contacts and communications between the underwriter defendants’ representatives and Kyverna’s management, directors, and lawyers, at a minimum, the underwriterd defendants should have known of Kyverna’s undisclosed then-existing problems and plans, and the Offering Document’s materially inaccurate, misleading, and incomplete statements and omissions, as detailed herein.

Class Period

This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and/or traceable to the Company's offering documents issued in connection with its February 2024 initial public offering.

Deadline

February 7 2025

Learn More

58

Days Left

SUI

Sun Communities, Inc.

Deadline

February 10 2025

Class Period

2/28/19 - 9/24/24

Allegations

According to the complaint, defendants provided investors with material information concerning SUI’s accounting practices and internal control over financial reporting. On September 24, 2024, after market close, an investment research report emerged calling into question the integrity of SUI’s Board and the integrity of the Company’s governance, controls, and financial disclosures. Investors and analysts reacted immediately to SUI’s revelation. The price of SUI’s common stock declined dramatically. From a closing market price of $139.10 per share on September 24, 2024, SUI’s stock price fell to a low of $137.48 per share on September 25, 2024.

Class Period

2/28/19 - 9/24/24

Deadline

February 10 2025

Learn More

58

Days Left

SAVA

Cassava Sciences, Inc.

Deadline

February 10 2025

Class Period

2/7/24 - 11/24/24

Allegations

According to the complaint, defendants provided investors with material information concerning Cassava’s leading drug candidate, simufilam. Defendants’ statements included, among other things, clear confidence in simufilam’s ability to treat Alzheimer’s Disease. On November 25, 2024, Cassava released topline results for the first of its two ongoing Phase 3 studies on simufilam, the “ReThink-ALZ” study. The results indicated that simufilam failed to meet each of the pre-specified primary, secondary, and exploratory endpoints; in sum, simufilam failed to outperform the placebo. Following this news, the price of Cassava’s common stock declined dramatically. From a closing market price of $26.48 per share on November 22, 2024, Cassava’s stock price fell to $4.30 per share on November 25, 2024, a decline of about 83.76% in the span of just a single day.

Class Period

2/7/24 - 11/24/24

Deadline

February 10 2025

Learn More

News

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.
View All News

Learn More

Export Regulations Lead to Slashed Sales Targets for ASML Holdings
Dutch semiconductor manufacturer ASML Holding N.V. missed the mark when it assured investors that it was on track for record sales by 2025.  So, when investors learned sales had short-circuited and ASML’s projections were off-track, they quickly sold off their stock, causing ASML’s stock price to plummet.  Now, some of those shareholders have filed a...Read more

December 13, 2024

Learn More

AIXI Delisted, Shareholders Litigate
In July, the NASDAQ delisted Chinese AI company Xiao-I because it had become a junk stock. Now, angry shareholders are suing the tech company to recover some of their lost investment. When Xiao-I launched its initial public offering in 2023, its executives should have known the company had problems. It wasn’t in compliance with Chinese...Read more

December 6, 2024

Learn More

Unhappy Holidays for Hasbro Investors
After dismal holiday sales, toy manufacturer Hasbro left investors holding a lump of coal. When investors quickly dumped their shares, Hasbro’s stock plummeted 11% overnight. Some of those angry shareholders have now filed a class action lawsuit against Hasbro hoping to recover their lost investment. During the early stages of the Covid pandemic, Hasbro loaded...Read more

December 5, 2024

Our World-Class Team

Levi & Korsinsky’s attorneys are admitted in over 40 state, federal, and appeal courts across the country. We have the specialized securities skills to achieve outstanding results, and our impressive variety of backgrounds means that we can go up against large companies of any kind and win. Our powerhouse attorneys have backgrounds in accounting, engineering, SEC enforcement, mathematics, regulatory analysis, international business, and prosecution, to name just a few. . .

View Attorneys